BioCryst is profitable. Now it wants to buy more rare disease drugs
CNBC · 26 days ago
Rare disease drug development is getting a boost from new funding models and a growing group of smaller biotech buyers.
Continue reading at CNBC →Social Justice News — https://social-justice.news/story/biocryst-is-profitable-now-it-wants-to-buy-more-rare-disease-drugs-41e1638e
● BreakingIowa judge dismisses Trump’s lawsuit against Des Moines Register and pollsterImmigration
View all →
Latest
'Of course it was!' Critics howl as JD Vance named as Trump's 'national security' threat
The Raw Story · 54 minutes ago
Disturbing video of ICE detaining a US citizen stuns ex-DHS lawyer: 'Troubling'
The Raw Story · 1 hour ago
RNC chair predicts GOP keeps House, 53 Senate seats
The Hill · 1 hour ago
Graham Bensinger: Seahawks PR Was Provided With Controversial Clip
Newsweek · 1 hour ago
Unifor keeps Stellantis workers on the job, as contract expires and automaker permanently shutters Brampton assembly
World Socialist Web Site · 1 hour ago
Mortgage rates surpass 7% for first time in 2 years amid inflation, Iran war
CBS News · 1 hour ago
What to expect from Taylor Swift as she releases new single, deluxe album
CBS News · 1 hour ago
🚨 Reporter RIPS Trump DIRECTLY in front of MELANIA…
MeidasTouch Network · 1 hour ago
